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Hospital-acquired pneumonia in nonintensive care unit wards
Meltem AVCI1, Onur ÖZGENÇ1, Ayten COŞKUNER1, Berna BOZCA1, Levent KIDAK2,
Gülşen MERMUT1, Mehmet Sezai TAŞBAKAN3, Neslihan GENÇ4, Gülşen GÜLOĞLU4, Alpay ARI1
Aim: To determine the incidence, risk factors, etiology, and antibiotic susceptibility of hospital-acquired pneumonia
(HAP) in nonintensive care units (non-ICU) and nonintubated adult patients.
Materials and methods: A prospective surveillance study was performed from January 2006 through December 2007
in the medical and surgical wards of the İzmir Teaching and Research Hospital.
Results: During the study period, data on 57,133 patients with a total of 413,515 patient-days were analyzed. A total of
106 HAP episodes occurred in 99 patients. The infection rate per 100 patients and per 1000 patient-days was found to
be 0.2% and 0.3%, respectively. HAP episodes were detected mostly in medical wards (66%). The mean age of patients
was 58.6 ± 15.9 and 73% of the patients were male. The most common intrinsic and extrinsic risk factors observed in
patients with HAP, according to the first episode, were cardiovascular disease (47%), central nervous system disease
(41%), malignancy (40%), hospitalization longer than 5 days (91%), antibiotic therapy (81%), previous endotracheal
intubation (40%), nasogastric tubes (38%), and H2 receptor antagonist/antiacid (37%). Moreover, 109 microorganisms
were isolated from 84% of HAP episodes. Overall, the most frequently isolated pathogens from HAP episodes were
Klebsiella pneumoniae (23%), Escherichia coli (21%), and Staphylococcus aureus (18%). These were mostly multidrugresistant. The crude mortality was found to be 25%.
Conclusion: Surveillance of HAP in non-ICU and nonintubated adult patients provides valuable guidance for empirical
antimicrobial therapy and infection control measures for some wards.
Key words: Hospital-acquired pneumonia, non-ICU medical and surgical wards, risk factors, etiology, antibiotic
susceptibility

Yoğun bakım dışı kliniklerde hastane kaynaklı pnömoni
Amaç: Yoğun bakım dışı kliniklerde entübasyon uygulanmayan erişkin hastalarda gelişen hastane kaynaklı pnömoni
insidansının, risk faktörlerinin, etyolojinin ve antibiyotik duyarlılıklarının belirlenmesi.
Yöntem ve gereç: Ocak 2006-Aralık 2007 tarihleri arasında hastanemiz dahili ve cerrahi kliniklerine yatırılan hastalar,
aktif prospektif sürveyans yöntemi ile izlendi.
Bulgular: Çalışma süresince, 57.133 hasta ve 413.515 hasta gününde, 99 hastada 106 nozokomiyal pnömoni atağı
saptandı. Hastane kaynaklı pnömoni hızı 100 hasta ve 1000 hasta-gününe göre sırasıyla, % 0,2 ve % 0,3 olarak bulundu.
Olguların % 66’sı dahili kliniklerinde yatmaktaydı. Hastane kaynaklı pnömoni olgularının yaş ortalaması 58.6 ± 15.9
(17-85) olup, % 73’ü erkekti. En sık saptanan intrensek ve ekstrensek risk faktörleri; kardiyovasküler hastalık (% 47),
santral sinir sistemi hastalığı (% 41), malignite (% 40), beş günden fazla hastanede yatış (% 91), antibiyotik tedavisi (%
76), önceden endotrekeal entübasyon (% 40), nazogastrik tüp (% 38) ve H2 reseptör antagonist/antiasit (% 37) olarak
saptandı. Atakların % 84’ünde 109 mikroorganizma izole edildi. En sık izole edilen etkenler sırasıyla Klebsiella pneumonae
(% 23), Escherichia coli (% 21) ve Staphylococcus aureus (% 18) olarak bulundu. Bu mikroorganizmaların çoğunluğu çok
ilaca dirençliydi. Kaba mortalite oranı % 25 olarak bulundu.
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Sonuç: Yoğun bakım dışı bazı kliniklerde hastane kaynaklı pnömoni sürveyansının yapılması, empirik antimikrobiyal
tedavi ve gerekli infeksiyon kontrol önlemlerinin alınabilmesi için yararlı bulunmuştur.
Anahtar sözcükler: Hastane kaynaklı pnömoni, yoğun bakım dışı dahili ve cerrahi klinikler, risk faktörleri, etyoloji ve
antibiyotik duyarlılığı

Introduction
Hospital-acquired pneumonia (HAP) is defined as
pneumonia that occurs 48 h or more after admission
and was not incubating at the time of admission,
according to the guidelines of the Joint Committee of
the American Thoracic Society and Infectious
Diseases Society of America (1). HAP is usually the
second or third most frequent nosocomial infection
(1-3).
HAP is associated with significant mortality (1).
In the literature, it has been reported that
approximately 60% of all deaths from nosocomial
infections are due to HAP (4). Besides mortality, HAP
increases hospital stay by an average of 7 to 9 days per
patient and results in significant economic cost (1).
HAP is the most common nosocomial infection
among intensive care unit (ICU) patients. In ICUs,
nearly 90% of all episodes of HAP occur during
mechanical ventilation; this type of HAP is known as
ventilator-associated pneumonia (VAP) (1).
Until recently, most studies of HAP have centered
on VAP because of its high incidence and mortality
(1). In contrast, there are limited data on HAP
developing in nonintubated patients or on healthcareassociated pneumonia (HCAP), and so information
about this issue is lacking (1,5-10). In the present
study, we aimed to determine the incidence, risk
factors, etiology, and antibiotic susceptibility of HAP
in non-ICU and nonintubated adult patients.
Materials and methods
The hospital in which the study was performed is
a 732-bed teaching hospital with approximately
30,000 admissions per year. The prospective study was
performed in the medical and surgical wards of the
hospital between January 2006 and December 2007.
Laboratory- and patient-based active surveillance
methods were used. HAP was defined according to
the standard definition of the Center for Disease
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Control (11). Patients in the ICU who were
mechanically ventilated were not included in the
study.
During the study period, infection control nurses
visited the patients’ wards daily. To assess HAP, they
investigated the medical and nursing notes,
microbiology reports, temperature charts, and
antibiotic treatment charts of each case in the wards.
If a patient had symptoms and signs of infection, the
nurses also consulted with the patient’s doctors. They
met with an infection control doctor weekly to assess
the hospital-acquired infections. If a patient was
determined to have HAP, he or she was also seen by
chest and infectious disease specialists. Data collected
from each HAP patient included: age, gender, date of
hospitalization, reason for admission, underlying
diseases, immunosuppression (chemotherapy and
corticosteroids), previous antibiotic therapy, and use
of H2 receptor antagonists or antacids. Previous
admission to the ICU, invasive procedures
(nasogastric tube, endotracheal intubation,
mechanical ventilation, tracheotomy, etc.), surgical
operations, data of onset, isolated microorganisms,
susceptibility patterns, and outcomes were also
recorded.
Bacterial isolates were identified by conventional
methods, and determination of antimicrobial
susceptibility was carried out using the disk diffusion
agar method. Antimicrobial susceptibilities were
determined according to the Clinical and Laboratory
Standards Institute (12).
To calculate nosocomial infection rates, the
number of patients in the medical and surgical wards
and the total number of patient-days were collected
each month. The overall HAP rates per patient and
per patient-days were calculated by dividing the total
number of HAP cases in the medical and surgical
wards by the total number of medical and surgical
patient wards (×100) and patient-days (×1000),
respectively (13).
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Statistical analysis was conducted by using
Student’s t-test for numeric variables and chi-square
and Fisher’s exact test for categorical variables.
Statistical significance was set to P < 0.05.

Table 2. The demographic characteristics and intrinsic and
extrinsic risk factors of the 99 patients according to the
first HAP episode (n = 99)*.
Demographics and intrinsic and extrinsic
risk factors

Number of
cases (%)

Results

Age 58.7 ± 15.7**
Gender (male)
Underlying diseases
Cardiovascular disease
Central nervous system disease
Malignancy
Diabetes mellitus
Neutropenia
Depressed level of consciousness
Chronic renal failure
Chronic obstructive lung disease
Trauma
Acute abdomen
Hepatic cirrhosis
Idiopathic thrombocytopenic purpura
Hospitalization >5 days
Antibiotic therapy
Previous endotracheal intubation
Nasogastric tube
H2 receptor antagonist and/or antacid
Surgery
Immunosuppression
Tracheotomy
Previous admission to ICU

72 (73)
92 (93)
47 (47)
41 (41)
40 (40)
36 (36)
28 (28)
20 (20)
20 (20)
15 (15)
5 (5)
5 (5)
2 (2)
1 (1)
90 (91)
80 (81)
40 (40)
38 (38)
37 (37)
34 (34)
32 (32)
9 (9)
6 (6)

During the study period, data on 57,133 patients
with a total of 413,515 patient-days were analyzed. A
total of 106 HAP episodes occurred in 99 patients.
The infection rates per 100 patients and per 1000
patient-days were found to be 0.2% and 0.3%,
respectively. The wards in which HAP episodes were
detected are listed in Table 1.
A total of 106 HAP episodes occurred: 2 patients
from internal medicine and 1 patient from the
neurology department each had 2 episodes of HAP, 2
patients from the neurology department each had 3
episodes of HAP, and 94 patients each had 1 episode.
The demographic characteristics and the intrinsic and
the extrinsic risk factors of the 99 patients according
to the first HAP episode are listed in Table 2. The
mean interval from hospital admission to the first
HAP episode was 18.7 ± 14.4 days (range, 3 to 90
days).
Table 1. Wards in which HAP episodes were detected (n = 106).
Departments
Medical
Internal medicine
Neurology
Surgical
Neurologic surgery
General surgery
Transplant unit
Ear, nose, and throat

Number of episodes (%)
72 (68)
41 (39)
31 (29)
34 (32)
14 (13)
12 (11)
5 (5)
3 (3)

Patients with HAP in medical wards were more
likely to have greater comorbidity (cardiovascular
disease and central nervous system disease), older age,
neutropenia,
immunosuppression,
previous
admission to the ICU, and longer stays than patients
with HAP in surgical wards (P < 0.05). Comparisons
of the demographic characteristics and some intrinsic

*Patients may have multiple risk factors.
**Mean ± SD

and extrinsic risk factors between patients in medical
wards and patients in surgical wards with HAP are
listed in Table 3.
A total of 109 microorganisms were isolated from
89 episodes of HAP. Twenty (22.47%) of these 89 HAP
episodes were polymicrobial. Gram-negative species
accounted for most of the monomicrobial infections,
whereas a combination of Staphylococcus aureus and
gram-negative species were the primary cause of
polymicrobial infections. Overall, the most frequently
isolated agents from HAP episodes were Klebsiella
pneumoniae (23%), Escherichia coli (21%),
Staphylococcus aureus (18%), Pseudomonas
aeruginosa (12%), and Acinetobacter baumannii
359
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Table 3. Comparison of the demographic characteristics and some intrinsic and extrinsic risk factors between patients in medical wards
and patients in surgical wards with HAP.
Factor

Patients in medical
wards, n = 65

Patients in surgical
wards, n = 34

P-value

63.6 ± 12.08*

49.7 ± 17.8*

<0.05

Gender (male)

47

25

NS

Cardiovascular disease

41

6

<0.05

Age, year

Central nervous system disease

34

7

<0.05

Malignancy

29

11

NS

Diabetes mellitus

23

13

NS

Neutropenia

28

0

<0.05

Depressed level of consciousness

14

6

NS

Chronic renal failure

15

5

NS

Chronic obstructive lung disease

11

4

NS

The mean interval from hospital admission to
the first HAP episode

20.9 ± 12.8*

14.5 ± 16.3*

<0.05

Antibiotic therapy

46

34

<0.05

Nasogastric tube

20

18

<0.05

H2 receptor antagonist and/or antacid

23

14

NS

Immunosuppression

28

4

<0.05

Previous admission to ICU

6

0

<0.05

NS: not significant
*Mean ± SD

(11%). These microorganisms were found to be the
predominant causative microbiologic agents in both
the immunosuppressive patients and the other
patients. The percentages of the microorganisms
isolated from HAP episodes are listed in Table 4. Sixty
percent of K. pneumoniae and 57% of E. coli were
ESBL-producing strains. Seventy percent of S. aureus
were methicillin-resistant. Eight percent of P.
aeruginosa and 58% of A. baumannii were
carbapenem-resistant.
Twenty-five patients died of HAP and the crude
mortality from HAP in 99 patients was found to be
25%. The demographic characteristics, some intrinsic
and extrinsic risk factors, inappropriate initial
antibiotic therapy, and the presence of multidrugresistant (MDR) pathogens were compared between
survivors and non-survivors. Non-survivors were
more likely to have had inappropriate initial antibiotic
therapy and multidrug-resistant (MDR) pathogens
than survivors (P < 0.05).
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Table 4. Percentage of the microorganisms isolated from HAP
episodes (n = 109).
Microorganisms
Klebsiella pneumoniae
Escherichia coli
Staphylococcus aureus
Pseudomonas aeruginosa
Acinetobacter baumannii
Stenotrophomonas maltophilia
Enterobacter cloacae
Coagulase negative staphylococci
Streptococcus pneumoniae
Proteus mirabilis

Percentage
23
21
18
12
11
5
5
4
1
1

Discussion
Cumulative incidence rates for HAP were
estimated in the range of 0.5% to 1% cases per 100
patients and a rate of 0.8 cases per 1000 patient-days
for U.S. hospitals, with the incidence increasing by as
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much as 6- to 20-fold in mechanically ventilated
patients (14). Although the incidence of HAP was
higher in intubated patients, it was reported that
around half of all cases were detected outside of the
ICU (6). In a prospective multicenter study of 12
Spanish academic hospitals evaluating HAP in
patients admitted to conventional medical, surgical,
and trauma wards, the incidence of HAP ranged from
1.3 to 5.9 cases per 1000 hospital admissions, with a
mean of 3.1 ± 1.4 per 1000 hospital admissions (5). In
a study from Japan, the incidence rate of HAP in
nonventilated patients was estimated at 0.9% per 100
patients (8). The incidence rates in ICU and in nonICU patients reported from a Turkish study were 9.5%
and 0.5%, respectively (10). In our study, the infection
rate per 100 patients and per 1000 patient-days for
HAP in medical or surgical wards was found to be
0.2% and 0.3%, respectively. These results show that
there may be variations in the rates of infections in
nonventilated general ward patients among hospitals
because of the characteristics of the patient population
and the hospital setting.
Several studies have established a number of risk
factors for the development of HAP in nonventilated
patient populations. These risk factors are: advanced
age, male gender, severity of illness, chronic lung
disease, trauma/head injury, depressed level of
consciousness, poor nutritional status, coma,
impaired airway reflexes, neuromuscular disease,
obesity, endotracheal intubation, nasogastric tube,
bronchoscopy, immunosuppressive therapy, thoracic
or upper abdominal surgery, duration of surgery,
duration of hospitalization, large-volume aspiration,
oropharyngeal colonization with gram-negative
bacilli, antibiotic therapy, reflux esophagitis, and
previous pneumonia (5,14,15). The risk factors for
HAP found in our study were mostly in accordance
with those previously reported (5,14,15). The intrinsic
risk factors observed in this study are as follows: most
patients were male; 56% of patients were 60 years or
older; and 92% had comorbidity, primarily including
cardiovascular disease, cerebrovascular disease,
malignancies, and diabetes mellitus. The extrinsic risk
factors were prolonged hospitalization and antibiotic
usage in most of the cases, instrumentation
(endotracheal intubation in 40% of the cases and a
nasogastric tube in 38% of the cases), H2 receptor

antagonist and/or antacid usage in 37% of the cases,
and surgery and immunosuppression in 33% of the
cases.
In the present study, a particularly great number
of HAP episodes occurred in medical wards. This
result was similar to those in the Spanish multicenter
study, but contrary to others reported (16,17). The
explanation for our finding could be that, compared
with the patients with HAP in surgical wards, those
in medical wards were older patients and had greater
comorbidity, neutropenia, immunosuppression,
previous admission to the ICU, and longer stays.
Early-onset bacterial HAP occurs during the first
4 days of the hospital stay and is more frequently
caused by Streptococcus pneumonia, Haemophilus
influenzae, or methicillin-susceptible S. aureus.
Conversely, late-onset HAP occurs after 4 days and is
more commonly caused by Klebsiella, Acinetobacter
spp., P. aeruginosa, or methicillin-resistant S. aureus
(MRSA) (17,18). Few data are available about
bacteriology in patients with HAP and HCAP who are
not mechanically ventilated (1,19). In the Spanish
multicenter study, although most of the patients were
hospitalized for more than 5 days, the most frequent
pathogens were S. pneumoniae, L. pneumophila,
Aspergillus spp., P. aeruginosa, and several
Enterobacteriaceae species (5). In a recent study of 10
Asian countries (20), MRSA, Acinetobacter species,
ESBL-producing E. coli and Klebsiella, and P.
aeruginosa were found to be the most common
pathogens causing HAP and VAP. According to
prospectively collected hospital-wide surveillance
data at the University of North Carolina, in general,
the bacteriology of nonventilated patients was similar
to that of ventilated patients, including infection with
MDR pathogens such as MRSA, P. aeruginosa,
Acinetobacter species, and K. pneumoniae. It was also
reported that some organisms like MRSA and K.
pneumoniae were more common in nonventilated
than in ventilated patients, whereas P. aeruginosa,
Stenotrophomonas maltophilia, and Acinetobacter
species were more common in patients with VAP (19).
Similarly to the Asian and University of North
Carolina studies, in this study, the most commonly
isolated pathogens from HAP episodes in the medical
and surgical wards were K. pneumoniae, E. coli, S.
aureus, P. aeruginosa, and A. baumannii, and those
were mostly MDR. Emergence of drug-resistant
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pathogens could be related to prior inappropriate
antibiotic use such as overly frequent use or misuse of
antibiotics, severity of underlying diseases, long
duration of hospitalization, and lack of effective
hospital infection control in these units.
The crude mortality rates reported for HAP,
including VAP, have ranged between 30% and 88.9%
(1,9). However, it was reported that many of these
patients with HAP died of their underlying diseases
rather than pneumonia (1). In the present study, the
crude mortality rate was found to be 25%. This was
lower than in some other studies (8,9), whereas it was
in accordance with the Spanish multicenter study (5).
It has been stated that the absence or presence of risk
factors for MDR pathogens should be initially
questioned for better outcomes and administration of
early, appropriate antibiotic therapy in adequate
doses; according to local surveillance data, this has
been associated with lower mortality rates (1).

In summary, this is one of the few studies of HAP
in general medical and surgical wards in
nonventilated patients as far as we know. HAP
occurred mainly in general medical ward patients.
Most patients were old and had comorbidity,
prolonged hospitalization, and antibiotic usage.
Klebsiella pneumoniae, Escherichia coli, and
Staphylococcus aureus were identified as the most
common organisms. These were mostly MDR. We
think that surveillance of HAP in non-ICU and
nonintubated adult patients provides valuable
guidance for empirical antimicrobial therapy and
infection control measures for some wards.
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